Recent Finacing
Recent Raise
Flexus Biosciences develops small-molecule cancer immunotherapies focused on targeting regulatory T cells and IDO-1 to reverse tumor immunosuppression and advance clinical candidates.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors